rs61751370
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM1BS2_Supporting
The ENST00000453960.7(MECP2):c.934G>A(p.Val312Ile) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,210,609 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V312L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000453960.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MECP2 | NM_001110792.2 | c.934G>A | p.Val312Ile | missense_variant | 3/3 | ENST00000453960.7 | NP_001104262.1 | |
MECP2 | NM_004992.4 | c.898G>A | p.Val300Ile | missense_variant | 4/4 | ENST00000303391.11 | NP_004983.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MECP2 | ENST00000453960.7 | c.934G>A | p.Val312Ile | missense_variant | 3/3 | 1 | NM_001110792.2 | ENSP00000395535 | ||
MECP2 | ENST00000303391.11 | c.898G>A | p.Val300Ile | missense_variant | 4/4 | 1 | NM_004992.4 | ENSP00000301948 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112383Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34521
GnomAD4 exome AF: 0.00000455 AC: 5AN: 1098226Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 2AN XY: 363582
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112383Hom.: 0 Cov.: 23 AF XY: 0.0000290 AC XY: 1AN XY: 34521
ClinVar
Submissions by phenotype
Rett syndrome Uncertain:4
Uncertain significance, no assertion criteria provided | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 17, 2015 | - - |
Uncertain significance, no assertion criteria provided | curation | RettBASE | Sep 27, 2012 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Nov 15, 2019 | - - |
Uncertain significance, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Jan 10, 2024 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as a variant of uncertain significance. At least the following criteria are met: Occurs in the well-characterized Transcriptional repression domain (TRD) of MECP2 (PM1). This variant has been identified as a de novo occurrence in an individual with Rett syndrome without confirmation of paternity and maternity (PM6). PMID: 11462237 This variant is absent from gnomAD (PM2_Supporting). - |
Syndromic X-linked intellectual disability Lubs type Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Sep 07, 2021 | A hemizygous missense variation in exon 3 of the MECP2 gene (chrX:g.154030930C>T; Depth: 45x) that results in the amino acid substitution of Isoleucine for Valine at codon 312 (p.Val312Ile; ENST00000453960.7) was detected. The p.Val312Ile variant has not been reported in the 1000 genomes database and has a minor allele frequency of 0.0009% in the gnomAD databases. The in silico predictions of the variant are possibly damaging by PolyPhen-2 (HumDiv) and damaging by LRT and MutationTaster2. The reference codon is conserved across species. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 27, 2018 | The p.V300I variant (also known as c.898G>A), located in coding exon 3 of the MECP2 gene, results from a G to A substitution at nucleotide position 898. The valine at codon 300 is replaced by isoleucine, an amino acid with highly similar properties. This variant has been reported as de novo in a female with classical Rett syndrome (Nicolao P et al. Hum. Mutat., 2001 Aug;18:132-40), as well as in a female with nonspecific intellectual disability and in her unaffected mother (Zvereff V et al. Brain Dev., 2012 Oct;34:750-5). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Autism, susceptibility to, X-linked 3 Uncertain:1
Uncertain significance, no assertion criteria provided | curation | RettBASE | Sep 27, 2012 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at